<DOC>
	<DOCNO>NCT00704678</DOCNO>
	<brief_summary>This study determine titration regimen SBR759 compare sevelamer HCl lower serum phosphate level Asian Chronic Kidney Disease patient hemodialysis</brief_summary>
	<brief_title>Optimal Titration Regimen SBR759 Lowering Serum Phosphate Levels Asian Chronic Kidney Disease Patients Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>Inclusion criterion Men woman least 18 year old 20 year old Japan . Stable maintenance hemodialysis 3 time per week . Controlled serum phosphate phosphatebinder therapy . Serum phosphate level &gt; 6.0 mg/dL ( &gt; 1.9 mmol/L ) prior study treatment initiation . Exclusion criterion Peritoneal dialysis nonconventional hemodialysis technique . Parathyroidectomy transplant schedule study . Uncontrolled hyperparathyroidism History hemochromatosis ferritin &gt; 800 Âµg/L . Clinically significant GI disorder Unstable medical condition Chronic Kidney Disease . Treated sevelamer HCl monotherapy SBR759 . Treated oral iron . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>hyperphosphatemia</keyword>
	<keyword>Asian</keyword>
	<keyword>patient</keyword>
</DOC>